Literature DB >> 2612129

Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing Group.

A L Barry1, P C Fuchs, R N Jones.   

Abstract

Multilaboratory studies have been carried out to establish quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents and four different control strains. For each drug-microorganism combination, 100 MIC values were recorded (20 from each of five laboratories). An acceptable range of MICs was defined as values that included greater than 95% of those 100 MICs. In a series of consecutive tests, less than or equal to 5% of the MIC values might be expected to be one doubling dilution interval above or below the limits defined in that way: at least 95% of those MIC determinations should be within the narrow control limits. The 39 antimicrobial agents provided 111 drug-microorganism combinations for which usable quality control limits could be defined. The greater than 95% rule yielded a narrow range (including only two dilution steps) with 58 of the 111 control limits, and 53 control limits permitted a more traditional three-dilution step range of MICs.

Mesh:

Substances:

Year:  1989        PMID: 2612129     DOI: 10.1016/0732-8893(89)90112-0

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  17 in total

1.  Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin.

Authors:  A L Barry; J H Jorgensen; D J Hardy; S D Allen; C N Baker; P C Fuchs; J C McLaughlin
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

2.  Eubacterium lentum ATCC 43055, a new reference strain for quality control of anaerobic susceptibility tests.

Authors:  A L Barry; R J Zabransky
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

3.  Broth microdilution susceptibility testing of Francisella tularensis: quality control limits for nine antimicrobial agents and three standard quality control strains.

Authors:  Steven D Brown; Karen Krisher; Maria M Traczewski
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

4.  Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacin.

Authors:  A L Barry; M A Cohen; J C Sesnie; P C Fuchs; J A Washington; P R Murray; C Baker
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

5.  Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin.

Authors:  S A Marshall; R N Jones; A Wanger; J A Washington; G V Doern; A L Leber; T H Haugen
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

6.  The Poisoned Well: Enhancing the Predictive Value of Antimicrobial Susceptibility Testing in the Era of Multidrug Resistance.

Authors:  Thea Brennan-Krohn; Kenneth P Smith; James E Kirby
Journal:  J Clin Microbiol       Date:  2017-05-03       Impact factor: 5.948

7.  Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazole.

Authors:  J H Rex; M A Pfaller; M Lancaster; F C Odds; A Bolmström; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

8.  Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.

Authors:  M A Pfaller; M Bale; B Buschelman; M Lancaster; A Espinel-Ingroff; J H Rex; M G Rinaldi; C R Cooper; M R McGinnis
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

9.  Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.

Authors:  M J Bale; R N Jones
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

10.  Proposed quality control guidelines for antimicrobial susceptibility tests using tilmicosin.

Authors:  T R Shryock; D W White; C S Werner; J M Staples
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.